When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Буллезный пемфигоид

最后审阅: 18 Aug 2025
最后更新: 11 Dec 2020

小结

Definição

História e exame físico

Principais fatores diagnósticos

  • наличие факторов риска
  • зуд
  • напряженные пузыри на нормальной или эритематозной коже
Detalhes completos

Outros fatores diagnósticos

  • эритематозные или уртикарные бляшки
  • поражения полости рта
Detalhes completos

Fatores de risco

  • возраст от 60 до 90 лет
  • главный комплекс гистосовместимости (ГКГС) аллели II класса (DQB1*0301)
  • мужской пол
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • биопсия кожи для гистопатологической оценки с помощью световой микроскопии
  • биопсия кожи для исследования методом прямой иммунофлюоресценции
  • исследование методом непрямой иммунофлуоресценции сыворотки
Detalhes completos

Investigações a serem consideradas

  • Анализ ELISA
Detalhes completos

Novos exames

  • иммуноблоттинг
  • иммунопреципитация
  • техника флюоресцентного наложения антигена (FOAM)

Algoritmo de tratamento

AGUDA

локализованные поражения у детей или взрослых

широко распространенные поражения у взрослых

широко распространенные поражения у детей

Colaboradores

Autores

Vesna Petronic-Rosic, MD, MSc, MBA

Professor and Chair

Department of Dermatology

Georgetown University

MedStar Washington Hospital Center

Washington

DC

Declarações

VPR declares that she has no competing interests.

Revisores

Lawrence Parish, MD

Clinical Professor of Dermatology and Cutaneous Biology

Director

Jefferson Center for International Dermatology

Jefferson Medical College

Thomas Jefferson University

Philadelphia

PA

Declarações

LP declares that he has no competing interests.

Timothy Patton, MD

Assistant Professor of Dermatology

Department of Dermatology

University of Pittsburgh

Pittsburgh

PA

Declarações

TP declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Cotell S, Robinson ND, Chan LS. Autoimmune blistering skin diseases. Am J Emerg Med. 2000;18:288-299. Resumo

Kirtschig G, Middleton P, Bennett C, et al. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;(10):CD002292.Texto completo  Resumo

Kirtschig G, Khumalo NP. Management of bullous pemphigoid: recommendations for immunomodulatory treatments. Am J Clin Dermatol. 2004;5:319-26. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
  • Буллезный пемфигоид images
  • Diagnósticos diferenciais

    • пузырчатка обыкновенная
    • Приобретённый буллезный эпидермолиз
    • Линейный IgA-зависимый дерматоз
    Mais Diagnósticos diferenciais
  • Diretrizes

    • Consensus on the treatment of autoimmune bullous dermatoses: bullous pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita
    • Japanese guidelines for the management of pemphigoid (including epidermolysis bullosa acquisita)
    Mais Diretrizes
  • Calculadoras

    показатель общего состояния пациента по шкале Карновского

    Mais Calculadoras
  • padlock-lockedConectar-se ou assinar para acessar todo o BMJ Best Practice

O uso deste conteúdo está sujeito ao nosso aviso legal